1/16/2007

Shareholders of Houston-based biotech Tanox agreed to accept Genentech's $919 million takeover offer. The deal is expected to streamline the partnership Genentech and Tanox share with Novartis AG for development of Tanox's asthma drug Xolair.

Related Summaries